Nuwellis (NUWE) Scheduled to Post Quarterly Earnings on Monday

Nuwellis (NASDAQ:NUWE) is set to announce its earnings results before the market opens on Monday, November 11th. Analysts expect the company to announce earnings of ($0.88) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Nuwellis (NASDAQ:NUWE) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($18.85) earnings per share (EPS) for the quarter, missing the consensus estimate of ($9.49) by ($9.36). Nuwellis had a negative net margin of 232.24% and a negative return on equity of 1,716.60%. The firm had revenue of $2.19 million for the quarter, compared to analyst estimates of $1.90 million. On average, analysts expect Nuwellis to post $-10 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Nuwellis Stock Up 2.8 %

Shares of NASDAQ NUWE opened at $1.81 on Friday. The stock’s 50 day moving average price is $1.49 and its two-hundred day moving average price is $4.03. Nuwellis has a 52-week low of $1.00 and a 52-week high of $31.15. The stock has a market capitalization of $3.38 million, a P/E ratio of -0.01 and a beta of 0.36.

Analysts Set New Price Targets

Several research firms have recently commented on NUWE. Roth Mkm reaffirmed a “buy” rating and set a $17.00 target price on shares of Nuwellis in a report on Tuesday, August 13th. Roth Capital raised Nuwellis to a “strong-buy” rating in a report on Monday, July 29th.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.